Atlas Neon Completes Tender Offer to Buy Out NGM Bio

Paul, Weiss advised The Column Group, LP (TCG) affiliate Atlas Neon Parent, Inc., in its cash tender offer to buy out NGM Biopharmaceuticals, Inc., a biotechnology company focused on discovering and developing transformative therapeutics for patients. An Atlas Neon merger subsidiary merged with and into NGM Bio, and NGM Bio became a privately held, wholly owned subsidiary of Atlas Neon Parent.

The Paul, Weiss team was led by corporate partners Austin Pollet and Luke Jennings, and included executive compensation partner Andrea Wahlquist Brown and counsel Sasha Belinkie and Christopher Gonnella; tax partner Matthew Jordan; intellectual property partner Jonathan Ashtor; litigation partner Andrew Gordon and counsel Steven Herzog; and antitrust counsel John Magruder and Chad de Souza.